Cigna Group Reports Q3 2026 Growth Driven by Evernorth and Cigna Healthcare
Cigna Group (CI) reported third-quarter 2026 results featuring adjusted revenue of $73.8 billion, a 6% increase year-over-year. The growth was primarily driven by strong performance in the Evernorth Health Services and Cigna Healthcare segments. Adjusted earnings per share (EPS) rose to $7.98 from $7.83 in the prior year period, prompting management to raise its full-year EPS guidance to a minimum of $30.60. Despite some headwinds, including a 22% decrease in Pharmacy Benefit Services (PBS) earnings due to contract renewals and strategic investments, the company maintains a strong outlook. Cigna is focusing on long-term efficiency through its 'Accelerate to 1' savings target, aiming for $3 billion in gross run-rate savings by 2030. While an exit from the ACA exchange market is expected to create a $200 million headwind in 2027, the company continues to execute share repurchases and reduce its debt-to-capitalization ratio.
Tickers: $CI
Topics: EPS guidance healthcare services medical cost ratio revenue growth